Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

340.79
Data as of Aug 22
 -0.72 / -0.21%
Today’s Change
235.02
Today|||52-Week Range
353.05
+23.82%
Year-to-Date

Stock Price Forecast

The 17 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 370.00, with a high estimate of 425.00 and a low estimate of 283.00. The median estimate represents a +8.57% increase from the last price of 340.79.

Analyst Recommendations

The current consensus among 20 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.56
Sales
$726.2M
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3.53%
 
 
 
 
 
 
Growthannually 23.63%
 
 
 
 
 
 

Sales

Growthquarterly 9.09%
 
 
 
 
 
 
Growthannually 33.39%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.